MINAKSHI KHANNA: Open Payments
NPI 1699932038 · FRESH MEADOWS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 52 payments from 26 companies in 2025. Trend: 2023 $388 · 2024 $1,314 · 2025 $1,316
Food & beverage: $1,316
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $139 |
| GENZYME CORPORATION | 4 | $139 |
| Merck Sharp & Dohme LLC | 3 | $97 |
| Incyte Corporation | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| Syndax Pharmaceuticals, Inc. | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Alexion Pharmaceuticals, Inc. | 3 | $54 |
| SOBI, INC | 2 | $52 |
| ABBVIE INC. | 2 | $47 |
Products named: RYBREVANT, SARCLISA, REVUFORJ, KEYTRUDA, ULTOMIRIS, TECVAYLI, MONJUVI, FABRAZYME.
Industry payments across NY — which companies pay providers there.
